PYCR1 and cancer: For example, PYCR1 overexpression can alter amino acid metabolism via the glutamine‐proline regulatory axis 34, which promotes aggressiveness in human cancers 35, 36, 37, and is thus considered to be a useful therapeutic target 37, 38.